SCHEMBL5646367

SCHEMBL5646367

CN(C(=O)Oc1ccc(NC(=O)C2CCCCC2)cn1)c1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.49
KDM4E B2RXH2 1/20 0.49
PTPN2 P17706 1/20 0.49
PTPN1 P18031 1/20 0.49
HPGD P15428 1/20 0.49
KMT2A Q03164 6/20 0.48
MEN1 O00255 5/20 0.48
RAB9A P51151 5/20 0.47
NPC1 O15118 4/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
GABRA5 P31644 1/20 0.46
TP53 P04637 2/20 0.44
LIPE Q05469 1/20 0.44
MAPT P10636 1/20 0.44
THRB P10828 1/20 0.44
CYP19A1 P11511 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5647513 0.85 EPHX2 (0.52) ALDH1A1KDM4EKMT2AMEN1RAB9A
SCHEMBL5687145 0.84 PKM (0.49) ALDH1A1KMT2AMEN1NPC1SMN1; SMN2
SCHEMBL5652008 0.83 MEN1 (0.65) ALDH1A1PTPN1HPGDKMT2AMEN1
SCHEMBL5647960 0.80 CXCR1 (0.56) KDM4EPTPN2PTPN1KMT2AMEN1
SCHEMBL5687800 0.79 ALDH1A1 (0.47) ALDH1A1KMT2AMEN1RAB9ANPC1
SCHEMBL5644860 0.79 KMT2A (0.49) ALDH1A1KDM4EKMT2AMEN1RAB9A
SCHEMBL5687152 0.77 NPC1 (0.47) ALDH1A1KDM4EHPGDKMT2AMEN1
SCHEMBL5914606 0.77 KMT2A (0.47) ALDH1A1KDM4EHPGDKMT2AMEN1
SCHEMBL5646539 0.77 LMNA (0.50) ALDH1A1KDM4EKMT2AMEN1RAB9A
SCHEMBL5689668 0.77 SMN1; SMN2 (0.47) ALDH1A1KDM4EHPGDKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060160865-A1 Pyridinyl carbamates NOVO NORDISK A/S (DK) 2006-07-20 US claimed
EP-1636205-A1 PYRIDINYL CARBAMATES AS HORMONE-SENSITIVE LIPASE INHIBITORS NOVO NORDISK A/S (DK) 2006-03-22 EP claimed
WO-2004111031-A1 PYRIDINYL CARBAMATES AS HORMONE-SENSITIVE LIPASE INHIBITORS NOVO NORDISK A/S (DK) 2004-12-23 WO claimed
EP-1458374-A2 COMPOUNDS AND USES THEREOF FOR DECREASING ACTIVITY OF HORMONE-SENSITIVE LIPASE NOVO NORDISK A/S (DK) 2004-09-22 EP claimed
US-20030166644-A1 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase NOVO NORDISK A/S (DK) 2003-09-04 US claimed
WO-2003051841-A2 COMPOUNDS AND USES THEREOF FOR DECREASING ACTIVITY OF HORMONE-SENSITIVE LIPASE NOVO NORDISK A/S (DK) 2003-06-26 WO claimed
US-7279470-B2 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase NOVO NORDISK A/S (DK) 2007-10-09 US disclosed
US-20060160865-A1 Pyridinyl carbamates NOVO NORDISK A/S (DK) 2006-07-20 US disclosed
US-7067517-B2 Use of compounds for decreasing activity of hormone-sensitive lipase NERO NORDISK A/S (DK) 2006-06-27 US disclosed
EP-1636205-A1 PYRIDINYL CARBAMATES AS HORMONE-SENSITIVE LIPASE INHIBITORS NOVO NORDISK A/S (DK) 2006-03-22 EP disclosed
WO-2004111031-A1 PYRIDINYL CARBAMATES AS HORMONE-SENSITIVE LIPASE INHIBITORS NOVO NORDISK A/S (DK) 2004-12-23 WO disclosed
EP-1458375-A2 COMPOSITIONS FOR DECREASING ACTIVITY OF HORMONE-SENSITIVE LIPASE NOVO NORDISK A/S (DK) 2004-09-22 EP disclosed
EP-1458374-A2 COMPOUNDS AND USES THEREOF FOR DECREASING ACTIVITY OF HORMONE-SENSITIVE LIPASE NOVO NORDISK A/S (DK) 2004-09-22 EP disclosed
US-20030166644-A1 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase NOVO NORDISK A/S (DK) 2003-09-04 US disclosed
US-20030166690-A1 Use of compounds for decreasing activity of hormone-sensitive NOVO NORDISK A/S (DK) 2003-09-04 US disclosed
WO-2003051842-A2 COMPOSITIONS DECREASING ACTIVITY OF HORMONE-SENSITIVE LIPASE NOVO NORDISK A/S (DK) 2003-06-26 WO disclosed
WO-2003051841-A2 COMPOUNDS AND USES THEREOF FOR DECREASING ACTIVITY OF HORMONE-SENSITIVE LIPASE NOVO NORDISK A/S (DK) 2003-06-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030166644-A1 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase LIPE, PNLIP, LPL ALDH1A1 1304/4885KDM4E 3457/4885PTPN2 1089/4885
US-20030166690-A1 Use of compounds for decreasing activity of hormone-sensitive LIPE, PNLIP, LPL ALDH1A1 1599/4885KDM4E 3778/4885PTPN2 1238/4885
US-20060160865-A1 Pyridinyl carbamates LIPE, PNLIP, LPL ALDH1A1 2231/4885KDM4E 996/4885PTPN2 1441/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.